Review
Open access
STRUCTURE–ACTIVITY RELATIONSHIPS AND FUTURE PROSPECTS OF IMATINIB AND NILOTINIB DERIVATIVES IN BCR::ABL1 TYROSINE KINASE INHIBITION
Abstract
Materials and methods. A literature review was conducted based on scientific publications investigating imatinib and nilotinib derivatives. Structural modification strategies, including aromatic and heterocyclic fragment modification, halogen and trifluoromethyl (CF₃) substitution, sp³-rich fragment introduction, hybrid molecule design, and improvement of resistance to drug efflux, were comparatively analyzed. Biochemical kinase inhibition data were distinguished from cellular antiproliferative activity.